The Lineberger Cancer Center Grand Rounds works with a multidisciplinary team of healthcare professionals, representatives, and leaders to produce the Lineberger Cancer Center Grand Rounds.


Our Planning Committee determines what knowledge gaps exist for our primarily North Carolina user base. Grand Rounds planning committee members work to select the topics and presenters throughout the year.

 

2025 Lineberger Cancer Center Grand Rounds Planning Committee:

Course Directors

Jared Weiss, MDDeborah Marie Stephens, DO1

Committee Members

Jared Weiss, MDDeborah Marie Stephens, DOVictoria Bae-Jump, MD, PhD2
Megan McElfresh, PA-CTatjana Grgic, PharmD, BCOP, CPPGaorav Gupta, MD, PhD3
Dominique Higgins, MD, PhDLee Jamison, MDCecilia Levandowski, MD, PhD
Mihir Patel, MD4Kimberly Riddick, BSN, RN, NPD-BCAndrew Smitherman, MD, MSc
Philip Spanheimer, MDPatty Spears, BS, FASCOMary Beth Westerman, MD

 

Financial Disclosures

  1. Dr. Stephens has served on advisory boards for Abbvie, AstraZeneca, BeOne, BMS, Genentech, Pfizer, Pharmacyclics, J&J. These were one time consulting efforts, but she is asked periodically to serve on additional boards. She is a consultant for Abbvie and this is an ongoing relationship. She has also received research grants research grants to Lineberger Comprehensive Cancer Center from BeOne, which are ongoing.
  2. Dr. Bae-Jump is on the Data Safety Monitoring Board for Gilead (2025 to present) and received a research grant from Merck (ended January 2024).
  3. Dr. Gupta holds stock in Naveris, Inc., receives a research grant from Merck and Co. (until 6/2026), and received a research grant from Breakpoint Therapeutics (ended 12/2024).
  4. Johnson & Johnson.
  5. These activities have been planned and implemented under the sole supervision of the Course Directors, Jared Weiss, MD, and Deborah Marie Stephens, DO of the UNC School of Medicine, and the planning committee in association with the UNC Office of Continuing Professional Development (CPD). Dr. Stephens has served on advisory boards for Abbvie, AstraZeneca, BeOne, BMS, Genentech, Pfizer, Pharmacyclics, J&J. These were one time consulting efforts, but she is asked periodically to serve on additional boards. She is a consultant for Abbvie and this is an ongoing relationship. She has also received research grants research grants to Lineberger Comprehensive Cancer Center from BeOne, which are ongoing. CPD staff have no relevant financial relationships with ineligible companies as defined by the ACCME. The planning committee members and their relevant financial relationships with ineligible companies as defined by the ACCME can be found at https://learn.unclcn.org/content/unclcn-webinar-planning-committee